Ascending flaccid paralysis secondary to hypokalemia in a cancer patient using abiraterone - a case report.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug safety"
DOI: 10.2174/1574886317666220425140053
Abstract: BACKGROUND Prostate cancer (PC) is the most common type of neoplasm in men and the fourth leading cause of mortality in Brazil. The prostate cancer refractory metastatic castration can be treated with abiraterone acetate (AA).… read more here.
Keywords: flaccid paralysis; paralysis secondary; report; case ... See more keywords